Over a four-year period, 26 consecutive patients with Guillain-Barré syndrome (GBS) were seen. Their ages ranged from 18 months to 68 years. Fifteen were male and 11 female. The crude annual incidence was estimated to be 1.5 per 100 000 population. East Indians made up the majority of the patients. An antecedent infection was reported in 65% of patients. Significant pain was present in half of the cohort. F-wave abnormalities were the commonest electrophysiological disturbance. Twenty-nine per cent of patients required ventilation. Intravenous immunoglobulin (IVIG) treatment was beneficial in 88% of patients. Eighty-four per cent made a complete or near complete recovery. One patient died. Keywords: Guillain-Barré Syndrome, Trinidad "El ...
Guillain-Barré syndrome is a complex disorder that affects around 0.5-2 individuals per 100,000 per ...
Background: GBS described as a condition associated with symmetrical weakness of the limbs, and hypo...
Guillain–Barre´ syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediate...
© 2015 Sociedad Medica de Santiago. All rights reserved.Background: Guillain-Barré syndrome (GBS) is...
INTRODUCTION: There are few epidemiologic studies concerning Guillain-Barré syndrome (GBS). Due to d...
Background: Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized...
International audienceThe Guillain–Barré syndrome (GBS) has been reported as a possible complication...
Introduction: Guillain-Barré syndrome, an acute polyradiculoneuropathy that presents with weakness a...
Introduction: According to most studies, the incidence of Guillain-Barré syndrome increases with age...
Purpose. The primary purpose of this study is to evaluate the demographic, clinical and laboratory f...
Artículo de publicación ISIBackground: Guillain-Barre syndrome (GBS) is the commonest cause of acute...
Guillain-Barré syndrome is a complex disorder that affects around 0.5-2 individuals per 100 000 per ...
Background Guillain-Barré syndrome (GBS) is an immune-mediated polyneuropathy characterised by progr...
INTRODUCTION: There are few epidemiologic studies concerning Guillain-Barré syndrome (GBS). Due to d...
Introduction: Guillain-Barré Syndrome (GBS) is defined as progressive polyradiculoneuropathy chara...
Guillain-Barré syndrome is a complex disorder that affects around 0.5-2 individuals per 100,000 per ...
Background: GBS described as a condition associated with symmetrical weakness of the limbs, and hypo...
Guillain–Barre´ syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediate...
© 2015 Sociedad Medica de Santiago. All rights reserved.Background: Guillain-Barré syndrome (GBS) is...
INTRODUCTION: There are few epidemiologic studies concerning Guillain-Barré syndrome (GBS). Due to d...
Background: Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized...
International audienceThe Guillain–Barré syndrome (GBS) has been reported as a possible complication...
Introduction: Guillain-Barré syndrome, an acute polyradiculoneuropathy that presents with weakness a...
Introduction: According to most studies, the incidence of Guillain-Barré syndrome increases with age...
Purpose. The primary purpose of this study is to evaluate the demographic, clinical and laboratory f...
Artículo de publicación ISIBackground: Guillain-Barre syndrome (GBS) is the commonest cause of acute...
Guillain-Barré syndrome is a complex disorder that affects around 0.5-2 individuals per 100 000 per ...
Background Guillain-Barré syndrome (GBS) is an immune-mediated polyneuropathy characterised by progr...
INTRODUCTION: There are few epidemiologic studies concerning Guillain-Barré syndrome (GBS). Due to d...
Introduction: Guillain-Barré Syndrome (GBS) is defined as progressive polyradiculoneuropathy chara...
Guillain-Barré syndrome is a complex disorder that affects around 0.5-2 individuals per 100,000 per ...
Background: GBS described as a condition associated with symmetrical weakness of the limbs, and hypo...
Guillain–Barre´ syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediate...